BeOne Medicines is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies, including targeted small molecules and immuno-oncology biologics. Its integrated approach spans in-house research, clinical development, and manufacturing, enabling rapid advancement of a pipeline with over 45 assets and 175 trials worldwide. With a mission to make next-generation treatments accessible and affordable, BeOne operates across major hubs in the U.S., China, Europe, and beyond, addressing hematologic malignancies and solid tumors through cutting-edge science and strategic partnerships.
Source: Great Place to Work® 2021 Global Employee Engagement Study
